When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 Visninger
• 07/10/23
0
0
Indlejre
administrator
Abonnenter
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer